Cargando…
The inducible nitric oxide synthase-inhibitor 1400W as a potential treatment for retinal diseases
Autores principales: | Schnichels, Sven, Joachim, Stephanie C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224120/ https://www.ncbi.nlm.nih.gov/pubmed/33269785 http://dx.doi.org/10.4103/1673-5374.300445 |
Ejemplares similares
-
1400 W, a selective inducible nitric oxide synthase inhibitor, mitigates early neuroinflammation and nitrooxidative stress in diisopropylfluorophosphate-induced short-term neurotoxicity rat model
por: Massey, Nyzil, et al.
Publicado: (2023) -
Disease-Modifying Effects of a Glial-targeted Inducible Nitric Oxide Synthase Inhibitor (1400W) in Mixed-sex Cohorts of a Rat Soman (GD) Model of Epilepsy
por: Vasanthi, Suraj S., et al.
Publicado: (2023) -
Disease-modifying effects of a glial-targeted inducible nitric oxide synthase inhibitor (1400W) in mixed-sex cohorts of a rat soman (GD) model of epilepsy
por: Vasanthi, Suraj S., et al.
Publicado: (2023) -
Nitric Oxide Synthase Inhibitors as Antidepressants
por: Wegener, Gregers, et al.
Publicado: (2010) -
N-[3-(Aminomethyl)benzyl]acetamidine (1400 W) as a Potential Immunomodulatory Agent
por: Mertas, Anna, et al.
Publicado: (2014)